Company Directory / Pharmaceuticals

A

Public · NYSE:AMRXFor profitPharmaceuticalsBridgewater, New Jersey, United States

Amneal Pharmaceuticals

Amneal Pharmaceuticals manufactures, markets and/or distributes more than 88 drugs in the United States.

Founded
1995
31 years ago
Staff
5001-10000
6,473 on LinkedIn
Followers
225k
on LinkedIn
Funding
$3.2B
as listed, USD

Amneal (NASDAQ: AMRX) is rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Our family delivers for yours through a robust U.S. generics business, a growing branded business and deepening portfolios in injectables, biosimilars and select international markets. We’ve bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. And we invest substantially in our people through leadership… Read all

Amneal (NASDAQ: AMRX) is rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Our family delivers for yours through a robust U.S. generics business, a growing branded business and deepening portfolios in injectables, biosimilars and select international markets. We’ve bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. And we invest substantially in our people through leadership development and employee well-being programs – all so we can deliver even more value. We are Amneal and We make healthy possible. Content is for informational purposes only and 3rd party content does not reflect Amneal’s opinions. Amneal has the right to remove comments that violate another’s copyright or intellectual property, mention an Amneal product, use profanity or are defamatory, promote and solicit for third-party sites, initiatives, or products, or are factually inaccurate or misleading or spam. Amneal recommends that you consult with your healthcare provider regarding personal health matters. To report a product complaint or adverse event related to an Amneal product, contact Drug Safety at 877-835-5472, option 3 or drugsafety@amneal.com. If you are currently experiencing a life-threatening event, please immediately contact 911.

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

5001-10000 people: larger than 99% of companies with a size listed. 6,473 people list it on LinkedIn.

Age

199519002026

31 years old.

Reach

Website ranked #453,247 in the world for traffic, about 77k visits a month. 225,149 followers on LinkedIn.

What it does

ManufacturingMedicalPharmaceutical

Funding, as listed

$3.2B raised in total

  • Rounds3
  • LatestPost ipo debt, Nov 2023
  • Latest amountUSD 2,350,000,000
  • Investors3

What the source datasets report. We have not watched these rounds ourselves, and do not hold this company in the startups database.

FoundersChintu Patel, Chirag Patel
Acquisitions made5
Apps1

Every detail we hold

Everything the source datasets list about Amneal Pharmaceuticals, field by field. Contact details are held but never shown.

The company

Name
Amneal Pharmaceuticals
Type
For profit
Status
Public · NYSE:AMRX
Founded
1995
Founders
Chintu Patel, Chirag Patel
Industry
Pharmaceuticals
Categories
Manufacturing, Medical, Pharmaceutical

Where

City
Bridgewater
Region
New Jersey
Country
United States
Markets
East Coast, Northeastern US

Size and reach

Staff band
5001-10000
People on LinkedIn
6,473
LinkedIn followers
225,149
Web traffic rank
#453,247
Monthly web visits
76,854
Apps
1

Funding, as listed

Total
$3,204,000,000 USD
Rounds
3
Latest round
Post ipo debt
Latest round date
Nov 2023
Latest amount
2,350,000,000 USD
Investors
3
Stock listing
NYSE:AMRX
Listing status
public

Corporate family

Acquisitions made
5

About this record

Sources
Crunchbase, LinkedIn
Last imported
Sept 2026

Growth, as the source summarises it

Amneal Pharmaceuticals may be growing as evidenced by a report indicating shareholders have seen a significant increase in value over the past year, despite a recent pullback. Additionally, the company has been recognized for double-digit growth, leading to an upward revision of its stock target by a securities firm. Amneal has also launched PEMRYDI RTU®, marking the introduction of a new oncology injectable medicine to its product line. Furthermore, the company has received U.S. FDA approval for an over-the-counter Naloxone Hydrochloride Nasal Spray, which is a critical emergency treatment for opioid overdose, and has begun supplying it to U.S. retail pharmacies.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

Pharmaceuticals in United States.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.